Diagnosis of fatty liver disease: is biopsy necessary?

&NA; Non‐alcoholic fatty liver disease is increasingly being recognized as an important and common condition, affecting approximately 20% of the general population. Although liver biopsy is currently the gold standard for diagnosis, there is a need for less invasive methods. Imaging by ultrasound, computerized tomography and magnetic resonance are all able to demonstrate fat. In this paper, these three imaging techniques are critically assessed. Ultrasound, although probably not the most reliable imaging method, has many advantages and, when positive, gives a high degree of certainty of the diagnosis depending on the prevalence of fatty liver in the population being studied. Unlike liver biopsy, none of these techniques is able to differentiate simple steatosis from non‐alcoholic steatohepatitis.

[1]  C. Thomsen,et al.  Quantification of liver fat using magnetic resonance spectroscopy. , 1994, Magnetic resonance imaging.

[2]  C. Tiribelli,et al.  Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis , 1995, Journal of magnetic resonance imaging : JMRI.

[3]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[4]  Fagan Tj.  Letter: Nomogram for Bayes theorem. , 1975 .

[5]  M. Fiévez,et al.  Prospective evaluation of the diagnostic accuracy of liver ultrasonography. , 1981, Gut.

[6]  A. Scheen,et al.  Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty , 1998, International Journal of Obesity.

[7]  K. Dewbury,et al.  Ultrasound in the detection of chronic liver disease (the "bright liver"). , 1979, The British journal of radiology.

[8]  K. Dewbury,et al.  The accuracy of ultrasound in the detection of cirrhosis of the liver. , 1979, The British journal of radiology.

[9]  G. Bydder,et al.  Accuracy of computed tomography in diagnosis of fatty liver. , 1980, British medical journal.

[10]  G. Brandi,et al.  Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.

[11]  A. Grant,et al.  Guidelines on the use of liver biopsy in clinical practice , 1999, Gut.

[12]  H. Nomura,et al.  Prevalence of fatty liver in a general population of Okinawa, Japan. , 1988, Japanese journal of medicine.

[13]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[14]  P. Christoffersen,et al.  Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties. , 1977, Scandinavian journal of gastroenterology.

[15]  C. Langlotz,et al.  Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT. , 1998, AJR. American journal of roentgenology.

[16]  K. Yamaoka,et al.  Test validity of periodic liver function tests in a population of Japanese male bank employees. , 2001, Journal of clinical epidemiology.

[17]  C. Tiribelli,et al.  Fatty Infiltration of the Liver: Quantification by 1H Localized Magnetic Resonance Spectroscopy and Comparison with Computed Tomography , 1993, Investigative radiology.

[18]  R. Buxton,et al.  Fatty infiltration of the liver: quantification with phase-contrast MR imaging at 1.5 T vs biopsy. , 1991, AJR. American journal of roentgenology.

[19]  G. Marchesini,et al.  Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. , 2001, Diabetes.

[20]  K. Seige.  [LIVER DISEASES AND DIABETES MELLITUS]. , 1963, Zeitschrift fur arztliche Fortbildung.

[21]  I. Suramo,et al.  Evaluation of liver steatotic and fibrous content by computerized tomography and ultrasound. , 1983, Scandinavian journal of gastroenterology.

[22]  M. Graif,et al.  Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease. , 2000, Investigative radiology.

[23]  A. Burroughs,et al.  Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. , 1995, Gut.

[24]  J. Maxwell,et al.  Ultrasound scanning in the detection of hepatic fibrosis and steatosis. , 1986, British medical journal.

[25]  R. Hanson,et al.  The natural history of nonalcoholic steatohepatitis: A follow‐up study of forty‐two patients for up to 21 years , 1990, Hepatology.

[26]  C. Riely,et al.  Quantitative US attenuation in normal liver and in patients with diffuse liver disease: importance of fat. , 1986, Radiology.

[27]  N. Sanford,et al.  Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? , 1985, Gastroenterology.

[28]  K. Dewbury,et al.  The accuracy of ultrasound in the detection of fatty infiltration of the liver. , 1980, The British journal of radiology.

[29]  B. Goldberg,et al.  Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. , 1986, AJR. American journal of roentgenology.

[30]  W. T. Dixon.  Simple proton spectroscopic imaging. , 1984, Radiology.

[31]  J. Ophir,et al.  Correlation of ultrasonic attenuation with pathologic fat and fibrosis in liver disease. , 1988, Ultrasound in medicine & biology.

[32]  T H Shawker,et al.  Quantitative estimation of liver attenuation and echogenicity: normal state versus diffuse liver disease. , 1987, Radiology.

[33]  L Dalla Palma,et al.  Noninvasive in vivo quantitative assessment of fat content in human liver. , 1997, Journal of hepatology.

[34]  K. Lindor,et al.  Treatment of Nonalcoholic Fatty Liver: Present and Emerging Therapies , 2001, Seminars in liver disease.

[35]  T. J. Fagan,et al.  Nomogram for Bayes's theorem , 1975 .

[36]  L Axel,et al.  Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease. , 1980, Radiology.

[37]  A. Joseph,et al.  Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. , 1991, Clinical radiology.

[38]  P. D. James,et al.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. , 2001, Journal of hepatology.

[39]  L. Castéra,et al.  Pain experienced during percutaneous liver biopsy , 1999, Hepatology.

[40]  R. Russell,et al.  A comparison of computed tomography, ultrasound and scintigraphy in the diagnosis of alcoholic liver disease. , 1984, The British journal of radiology.

[41]  L. Schwartz,et al.  Qualitative assessment of liver for fatty infiltration on contrast-enhanced CT: is muscle a better standard of reference than spleen? , 1997, Journal of computer assisted tomography.